Selecta Biosciences Inc.

NASDAQ: SELB · Real-Time Price · USD
0.88
-0.08 (-8.12%)
At close: Nov 13, 2023, 10:00 PM

Selecta Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-77.42M -219.71M 35.38M -25.69M
Depreciation & Amortization
1.15M 764K 1.29M 1.25M
Stock-Based Compensation
6.58M n/a 11.19M 7.72M
Other Working Capital
n/a -3.56M -63.79M -45.5M
Other Non-Cash Items
n/a 160.7M -19.11M 2.13M
Deferred Income Tax
287K -19M n/a 2.4M
Change in Working Capital
n/a 3.56M -60.38M -48.19M
Operating Cash Flow
-23.67M -51.16M -31.63M -60.38M
Capital Expenditures
-9.09M -206K -1.2M -1.08M
Cash Acquisitions
n/a n/a 13.8M 2M
Purchase of Investments
n/a n/a -33.5M -32.45M
Sales Maturities Of Investments
n/a 28.25M 19.7M 16.4M
Other Investing Acitivies
351K 6.56M -13.8M -2M
Investing Cash Flow
-8.74M 34.61M -15M -17.14M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a 231K n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
128.43M -13.14M 39.22M 52.9M
Financial Cash Flow
168.43M -13.14M 39.22M 52.9M
Net Cash Flow
135.99M -29.75M -7.4M -24.63M
Free Cash Flow
-32.77M -51.37M -32.83M -61.47M